PRO26 THE NICE APPRAISAL OF BUROSUMAB FOR THE TREATMENT OF XLH: EVALUATING THE LIFELONG OUTCOMES AND COST-EFFECTIVENESS OF CORRECTING DEFORMITY WHEN TREATING CHILDREN AND ADOLESCENTS WITH A GROWING SKELETON
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2356
https://www.valueinhealthjournal.com/article/S1098-3015(19)34734-5/fulltext
Title :
PRO26 THE NICE APPRAISAL OF BUROSUMAB FOR THE TREATMENT OF XLH: EVALUATING THE LIFELONG OUTCOMES AND COST-EFFECTIVENESS OF CORRECTING DEFORMITY WHEN TREATING CHILDREN AND ADOLESCENTS WITH A GROWING SKELETON
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34734-5&doi=10.1016/j.jval.2019.09.2356
First page :
Section Title :
Open access? :
No
Section Order :
12057